PDS Biotechnology Corporation
PDSB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$37,610 | -$42,942 | -$40,855 | -$16,918 |
| Dep. & Amort. | $21 | $17 | $0 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,848 | $7,614 | $5,196 | $4,110 |
| Change in WC | -$5,752 | -$199 | $4,475 | $76 |
| Other Non-Cash | $1,463 | $1,874 | $5,474 | $241 |
| Operating Cash Flow | -$35,030 | -$33,636 | -$25,710 | -$12,486 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$29 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$29 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,181 | -$59 | $25,000 | $0 |
| Stock Issued | $22,595 | $16,127 | $9,856 | $48,545 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $774 | $309 | -$569 | $344 |
| Financing Cash Flow | $20,188 | $16,376 | $34,287 | $48,889 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$14,871 | -$17,260 | $8,578 | $36,403 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $56,561 | $73,820 | $65,243 | $28,840 |
| End Cash | $41,690 | $56,561 | $73,820 | $65,243 |
| Free Cash Flow | -$35,059 | -$33,636 | -$25,710 | -$12,486 |